Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cheng Andrew Insider Profile
11 Followers
Cheng Andrew, Director at Arbutus Biopharma, holds ― shares in Arbutus Biopharma (Ticker: ABUS), holds 461.00K shares in Akero Therapeutics (Ticker: AKRO), holds 17.49K shares in Vera Therapeutics (Ticker: VERA). Most recently, Cheng Andrew ― shares of Arbutus Biopharma on ― for an estimated value of ―.
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+14.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Cheng Andrew holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 04, 2022 - Jan 04, 2023
Return:+114.50%
The most profitable trade made by Cheng Andrew
Cheng Andrew's Trading History
Arbutus Biopharma
―
Director
―
―
Akero Therapeutics
Sep 25, 2023
President & CEO, Director
Uninformative Sell
84.67K
$23.32M
Vera Therapeutics
May 18, 2021
Director
Uninformative Buy
―
$239.76K
List of latest transactions for each holding click on a transaction to see Cheng Andrew's performance on stock
You May Also Like
Cheng Andrew insider profile FAQ
What is the percentage of profitable transactions made by Cheng Andrew?
The percentage of profitable transactions made by Cheng Andrew is 57%.
What is the average return per transaction made by Cheng Andrew?
The average return per transaction made by Cheng Andrew is 14.10%.
What stocks does Cheng Andrew hold?
Cheng Andrew holds: ABUS, AKRO, VERA stocks.
What was Cheng Andrew’s latest transaction?
Cheng Andrew latest transaction was an Uninformative Buy of ―.
What was Cheng Andrew's most profitable transaction?
Cheng Andrew’s most profitable transaction was an Informative Buy of AKRO stock on January 4, 2022. The return on the trade was 114.50%.
What is Cheng Andrew's role in Arbutus Biopharma?
Cheng Andrew's role in Arbutus Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.